STAT1 and ovarian carcinoma: Another study found that the blockade of Jaks by AG490 enhanced the sensitivity of cisplatin-resistant ovarian cancer cells to AMD473, but not cisplatin 41, highlighting the importance of an elevated expression of STAT1 in the acquisition of the “off-target effects of alisertib”.